Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations

References

• Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009;373:956-66
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11
   PubMed Web of Science ®Google Scholar
• Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J 1987;8:471-83
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8
   PubMed Web of Science ®Google Scholar
• Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol 1994;23:1076-8
   Google Scholar
• Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart 2012;98(4 Suppl):iv7-iv13
   Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-704
   PubMed Web of Science ®Google Scholar
• Kapadia S. Three-year outcomes of Transcatheter Valve Replacement (TAVR) in “inoperable” patients with severe aortic stenosis: the PARTNER trial. Poster presented at: Transcatheter Cardiovascular Therapeutics (TCT) Miami, Florida. October 22-26, 2012
   Google Scholar
• Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012;42:S1-44
   PubMed Web of Science ®Google Scholar
• Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 2005;21:165-71
   PubMed Web of Science ®Google Scholar
• National Insititute for Health and Care Excellence (NICE). “Guide to the Methods Of Technology Appraisal 2013. United Kingdom: NICE, 2013. http://publications.nice.org.uk/pmg9. Accessed 18 March 2014
   Google Scholar
• World Health Organization. World Health Organization: Choosing Interventions that are Cost-Effective (WHO-CHOICE). Geneva: World Health Organization, 2012. http://www.who.int/choice/en/. Accessed 28 November 2013
   Google Scholar
• Gosden TB, Torgerson DJ. Economics notes: converting international cost effectiveness data to UK prices. BMJ 2002;325:275-6
   PubMed Web of Science ®Google Scholar
• Rivero-Arias O, Gray A. The multinational nature of cost-effectiveness analyses alongside multinational clinical trials. Value Health 2010;13:34-41
   Google Scholar
• Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98(5):370-6
   Google Scholar
• Watt M, Mealing S, Sculpher M, et al. The authors' reply. Heart 2012;98(13):1033-4
   Google Scholar
• Neyt M, Van Brabandt H. Cost-effectiveness of transcatheter aortic valve replacement: overoptimistic study results and a call for publication of complete trial results. Heart 2012;98:1031-3
   Google Scholar
• Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ 2012;345:e4710
   Google Scholar
• Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 2012;345:e4710
   Google Scholar
• Organisation for Economic Co-operation and Development (OECD). Prices and Purchasing Power Parities (PPP). OECD StatExtracts. Paris, France: OECD, 2012. Available from: http://stats.oecd.org/Index.aspx?DataSetCode=PPPGDP. Accessed 28 November 2012
   Google Scholar
• Bureau of Labor Statistics. CPI Inflation Calculator. United States Department of Labor, 2012. Available from: http://www.bls.gov/data/inflation_calculator.htm. Accessed 28 November 2012
   Google Scholar
• Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (cohort B). Circulation 2012;125(9):1102-9
   Google Scholar
• Gada H, Kapadia SR, Tuzcu EM, et al. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 2012;109(9):1326-33
   Google Scholar
• Neyt M, Van Brabandt H, Devriese S, et al. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012;2:e001032. doi:10.1136/bmjopen-2012-001032
   Google Scholar
• Sehatzadeh S, Doble B, Xie F, et al. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (part B). Ont Health Technol Assess Ser [Internet] 2012;12(14):1-62. Available from: www.hqontario.ca/en/eds/tech/pdfs/2012/rev_TAVI_May.pdf
   Google Scholar
• Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg 2013;146(1):52-60. doi: 10.1016/j.jtcvs.2012.06.018
   Google Scholar
• Neyt M, Van BH, Van De Sande S, et al. Transcatheter Aortic Valve Implantation (TAVI): a Health Technology Assessment Update. Belgium: KCE 163C, 2011
   Google Scholar
• Scottish Health Technologies Group. Evidence Development Pilot Project: transcatheter aortic valve implantation in Scotland. Scottish Health Technologies Group, 2010. Available from: http://www.gla.ac.uk/media/media_218806_en.pdf. Accessed December 2013
   Google Scholar
• Gohler A, Geisler BP, Manne JM, et al. Utility estimates for decision-analytic modeling in chronic heart failure–health states based on New York Heart Association classes and number of rehospitalizations. Value Health 2009;12:185-7
   PubMed Web of Science ®Google Scholar
• Maliwa MA, van der Heijden GJ, Bots ML, et al. Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg 2003;11:381-7
   PubMedGoogle Scholar
• International Monetary Fund (IMF). World Economic Outlook Databases [WEO]. Washington D.C.: International Monetary Fund, 2012. Available from: http://www.imf.org/external/pubs/ft/weo/2011/02/weodata/weorept.aspx?sy=2011&ey=2012&scsm=1&ssd=1&sort=country&ds=.&br=1&pr1.x=30&pr1.y=15&c=998&s=PPPPC&grp=1&a=1. Accessed 18 March 2014
   Google Scholar
• Popma JJ, on behalf of the CoreValve US Clinical Investigators. CoreValve US Pivotal Trial Extreme Risk Iliofemoral Study Results. Presented 28 November 2013 at TCT 2013, San Francisco, CA
   Google Scholar
• Généreux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012;59:2317-26
   PubMed Web of Science ®Google Scholar
• Anderson GF, Reinhardt UE, Hussey PS, et al. It's the prices, stupid: why the United States is so different from other countries. Health Aff (Millwood) 2003;22:89-105
   Web of Science ®Google Scholar
• Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 2004;8:iii-192
   Web of Science ®Google Scholar
• Juni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60
   PubMed Web of Science ®Google Scholar
• Guyot P, Ades AE, Ouwens MJNM, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier Survival Curves. BMC Med Res Methodol 2012;12:9. doi:10.1186/1471-2288-12-9
   Google Scholar
• Latimer N. NICE DSU Technical Support Document 14: undertaking survival analysis for economic evaluations alongside clinical trials - Extrapolation with patient-level data. Natio, 2011. Available from: http://www.nicedsu.org.uk. Accessed 28 November 2012
   Google Scholar
• Hoyle MW, Henley W. Improved curve fits to summary survival data: application to economic evaluation of health technologies. BMC Med Res Methodol 2011;11:139. doi:10.1186/1471-2288-11-139
   Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) Trial (Cohort A). J Am Coll Cardiol 2012;60(25):2683-92
   Google Scholar
• Osnabrugge RL, Head SJ, Genders TS, et al. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg 2012;94:1954-60
   Google Scholar